Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,789,047,884
+$1,520,779,717 QoQ
Shares Held
38,901,001
+2.3% QoQ
Ownership
2.20%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#7
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. ABBV ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,789,047,884 | 38,901,001 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $8,268,268,167 | 38,016,774 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,149,182,858 | 40,041,940 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $9,644,748,676 | 41,654,784 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,740,354,174 | 41,700,001 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $8,621,692,258 | 41,149,734 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,052,764,430 | 39,689,164 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $7,645,803,726 | 38,716,851 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $6,388,035,639 | 37,243,678 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $6,404,764,558 | 35,171,689 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $5,277,121,340 | 34,052,535 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $4,796,084,045 | 32,175,527 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $4,211,800,181 | 31,261,042 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,008,679,393 | 31,427,994 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,102,310,507 | 31,571,750 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,595,012,534 | 26,786,473 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,993,728,782 | 26,075,534 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,060,917,246 | 18,881,730 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,622,831,772 | 19,370,988 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,048,056,706 | 18,986,342 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,133,929,537 | 18,944,687 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,026,988,948 | 18,730,262 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,750,456,506 | 16,336,505 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,202,738,140 | 13,731,455 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,220,846,894 | 12,434,782 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $819,530,873 | 10,756,410 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||